Logo image of ELI.BR

ELIA GROUP SA/NV (ELI.BR) Stock Fundamental Analysis

EBR:ELI - Euronext Brussels - BE0003822393 - Common Stock - Currency: EUR

66.7  -1.05 (-1.55%)

Fundamental Rating

3

Overall ELI gets a fundamental rating of 3 out of 10. We evaluated ELI against 16 industry peers in the Electric Utilities industry. Both the profitability and financial health of ELI have multiple concerns. ELI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ELI was profitable.
In the past year ELI has reported a negative cash flow from operations.
ELI had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ELI reported negative operating cash flow in multiple years.
ELI.BR Yearly Net Income VS EBIT VS OCF VS FCFELI.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.54%, ELI is doing worse than 80.00% of the companies in the same industry.
With a Return On Equity value of 6.57%, ELI is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
The Return On Invested Capital of ELI (2.74%) is worse than 86.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ELI is significantly below the industry average of 9.28%.
Industry RankSector Rank
ROA 1.54%
ROE 6.57%
ROIC 2.74%
ROA(3y)1.62%
ROA(5y)1.67%
ROE(3y)6.29%
ROE(5y)6.24%
ROIC(3y)2.92%
ROIC(5y)3.23%
ELI.BR Yearly ROA, ROE, ROICELI.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8

1.3 Margins

ELI's Profit Margin of 9.72% is fine compared to the rest of the industry. ELI outperforms 73.33% of its industry peers.
In the last couple of years the Profit Margin of ELI has declined.
ELI has a better Operating Margin (19.30%) than 73.33% of its industry peers.
In the last couple of years the Operating Margin of ELI has declined.
ELI's Gross Margin of 43.75% is on the low side compared to the rest of the industry. ELI is outperformed by 60.00% of its industry peers.
In the last couple of years the Gross Margin of ELI has declined.
Industry RankSector Rank
OM 19.3%
PM (TTM) 9.72%
GM 43.75%
OM growth 3Y-12.99%
OM growth 5Y-5.8%
PM growth 3Y-9.3%
PM growth 5Y-9.9%
GM growth 3Y-5.05%
GM growth 5Y-3.05%
ELI.BR Yearly Profit, Operating, Gross MarginsELI.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

More info and screens

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELI is destroying value.
The number of shares outstanding for ELI remains at a similar level compared to 1 year ago.
ELI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ELI is higher compared to a year ago.
ELI.BR Yearly Shares OutstandingELI.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ELI.BR Yearly Total Debt VS Total AssetsELI.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.55, we must say that ELI is in the distress zone and has some risk of bankruptcy.
ELI's Altman-Z score of 0.55 is on the low side compared to the rest of the industry. ELI is outperformed by 80.00% of its industry peers.
A Debt/Equity ratio of 2.22 is on the high side and indicates that ELI has dependencies on debt financing.
With a Debt to Equity ratio value of 2.22, ELI is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.22
Debt/FCF N/A
Altman-Z 0.55
ROIC/WACC0.79
WACC3.47%
ELI.BR Yearly LT Debt VS Equity VS FCFELI.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B 6B 8B

2.3 Liquidity

ELI has a Current Ratio of 0.87. This is a bad value and indicates that ELI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ELI (0.87) is worse than 73.33% of its industry peers.
A Quick Ratio of 0.85 indicates that ELI may have some problems paying its short term obligations.
ELI has a Quick ratio of 0.85. This is comparable to the rest of the industry: ELI outperforms 46.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.85
ELI.BR Yearly Current Assets VS Current LiabilitesELI.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ELI have decreased by -0.88% in the last year.
Measured over the past years, ELI shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.12% on average per year.
Looking at the last year, ELI shows a very negative growth in Revenue. The Revenue has decreased by -13.66% in the last year.
The Revenue has been growing by 14.71% on average over the past years. This is quite good.
EPS 1Y (TTM)-0.88%
EPS 3Y6.78%
EPS 5Y-0.12%
EPS Q2Q%11.76%
Revenue 1Y (TTM)-13.66%
Revenue growth 3Y20.26%
Revenue growth 5Y14.71%
Sales Q2Q%1.32%

3.2 Future

ELI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.70% yearly.
ELI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.37% yearly.
EPS Next Y14.23%
EPS Next 2Y11.42%
EPS Next 3Y10.89%
EPS Next 5Y9.7%
Revenue Next Year1.29%
Revenue Next 2Y10.01%
Revenue Next 3Y12.71%
Revenue Next 5Y12.37%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ELI.BR Yearly Revenue VS EstimatesELI.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
ELI.BR Yearly EPS VS EstimatesELI.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.28, which indicates a correct valuation of ELI.
ELI's Price/Earnings ratio is in line with the industry average.
ELI is valuated rather cheaply when we compare the Price/Earnings ratio to 28.47, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.77 indicates a reasonable valuation of ELI.
66.67% of the companies in the same industry are more expensive than ELI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, ELI is valued rather cheaply.
Industry RankSector Rank
PE 14.28
Fwd PE 11.77
ELI.BR Price Earnings VS Forward Price EarningsELI.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELI is valued a bit more expensive than the industry average as 73.33% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.95
ELI.BR Per share dataELI.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y11.42%
EPS Next 3Y10.89%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.20%, ELI has a reasonable but not impressive dividend return.
In the last 3 months the price of ELI has falen by -23.16%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
With a Dividend Yield of 2.20, ELI pays less dividend than the industry average, which is at 4.37. 80.00% of the companies listed in the same industry pay a better dividend than ELI!
ELI's Dividend Yield is comparable with the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 2.2%

5.2 History

The dividend of ELI has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years5
Div Non Decr Years5
ELI.BR Yearly Dividends per shareELI.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.5 1 1.5

5.3 Sustainability

42.58% of the earnings are spent on dividend by ELI. This is a bit on the high side, but may be sustainable.
ELI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP42.58%
EPS Next 2Y11.42%
EPS Next 3Y10.89%
ELI.BR Yearly Income VS Free CF VS DividendELI.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B
ELI.BR Dividend Payout.ELI.BR Dividend Payout, showing the Payout Ratio.ELI.BR Dividend Payout.PayoutRetained Earnings

More info and screens

ELIA GROUP SA/NV

EBR:ELI (2/5/2025, 5:35:15 PM)

66.7

-1.05 (-1.55%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)11-29 2024-11-29
Earnings (Next)N/A N/A
Inst Owners16%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap4.90B
Analysts77.65
Price Target111.11 (66.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.2%
Yearly Dividend1.91
Dividend Growth(5Y)3.71%
DP42.58%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.02%
PT rev (3m)-8.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.85%
EPS NY rev (3m)1.85%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.48%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 14.28
Fwd PE 11.77
P/S 1.39
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 2
EV/EBITDA 11.95
EPS(TTM)4.67
EY7%
EPS(NY)5.67
Fwd EY8.49%
FCF(TTM)-55.45
FCFYN/A
OCF(TTM)-10.18
OCFYN/A
SpS48.07
BVpS71.19
TBVpS33.36
PEG (NY)1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.54%
ROE 6.57%
ROCE 3.77%
ROIC 2.74%
ROICexc 3.17%
ROICexgc 3.85%
OM 19.3%
PM (TTM) 9.72%
GM 43.75%
FCFM N/A
ROA(3y)1.62%
ROA(5y)1.67%
ROE(3y)6.29%
ROE(5y)6.24%
ROIC(3y)2.92%
ROIC(5y)3.23%
ROICexc(3y)3.76%
ROICexc(5y)3.9%
ROICexgc(3y)4.95%
ROICexgc(5y)5.19%
ROCE(3y)4.02%
ROCE(5y)4.44%
ROICexcg growth 3Y-2.67%
ROICexcg growth 5Y-10.8%
ROICexc growth 3Y-1.76%
ROICexc growth 5Y-6.46%
OM growth 3Y-12.99%
OM growth 5Y-5.8%
PM growth 3Y-9.3%
PM growth 5Y-9.9%
GM growth 3Y-5.05%
GM growth 5Y-3.05%
F-Score3
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 2.22
Debt/FCF N/A
Debt/EBITDA 9.2
Cap/Depr 573.52%
Cap/Sales 94.19%
Interest Coverage 2.73
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.85
Altman-Z 0.55
F-Score3
WACC3.47%
ROIC/WACC0.79
Cap/Depr(3y)327.32%
Cap/Depr(5y)309.75%
Cap/Sales(3y)50.5%
Cap/Sales(5y)50.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.88%
EPS 3Y6.78%
EPS 5Y-0.12%
EPS Q2Q%11.76%
EPS Next Y14.23%
EPS Next 2Y11.42%
EPS Next 3Y10.89%
EPS Next 5Y9.7%
Revenue 1Y (TTM)-13.66%
Revenue growth 3Y20.26%
Revenue growth 5Y14.71%
Sales Q2Q%1.32%
Revenue Next Year1.29%
Revenue Next 2Y10.01%
Revenue Next 3Y12.71%
Revenue Next 5Y12.37%
EBIT growth 1Y11.95%
EBIT growth 3Y4.64%
EBIT growth 5Y8.05%
EBIT Next Year116.55%
EBIT Next 3Y48.65%
EBIT Next 5Y36.59%
FCF growth 1Y-328.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-123.39%
OCF growth 3YN/A
OCF growth 5YN/A